This training curriculum for tuberculosis (TB) health care workers introduces principles of interpersonal communication and counseling of clients on TB and HIV and provides practical experience in TB and HIV counseling skills in a three-day workshop. The training package also includes PowerPoint presentations on parts 1, 2, and 4 for the trainers; and handouts for the participants.
The latest issue of the New Jersey Medical School Global Tuberculosis Institute’s Cultural Competency newsletter focused on patient advocacy. The issue was released in conjunction with World TB Day. It highlights the moving story of one patient’s experience with a TB diagnosis, and how she helped other TB patients, their loved ones and healthcare providers in the struggle against TB. The issue also includes information on confronting stigma, extrapulmonary TB and advocacy resources.
This brochure for patients describes the new 12-dose treatment for latent TB infection (LTBI).
This pocket-sized card for clinicians provides information on identifying those at risk for TB. The resource also includes content on latent TB infection testing, diagnosis, and treatment in adults.
This fact sheet describes the impact of HIV-TB co-infection. It also presents work currently being done to find and treat HIV-TB.
A 90-minute webinar about the basics of reading radiographs to diagnose TB disease. Intended for physicians and nurses who diagnose TB.
This fact sheet describes the burden of TB in women, the impact of TB on maternal health, and what can be done.
This website provides information regarding pediatric TB. Treatment challenges as well as the scope of the problem are discussed.
This document includes recommendations for improving the management of children with TB and of children living in families with TB. National and regional TB control programmes may wish to adapt these recommendations according to local circumstances.
This field guide is meant to serve as a tool for practitioners working with children at risk of infection or being sick with MDR TB. It should be considered complementary to existing recommendations.
